Fierce Biotech June 10, 2024
Sponsored By Montgomery County Economic Development Corporation

Drive or take the metro in any direction within Montgomery County, Maryland, and you’ll come across a life science company responsible for a major innovation. From the early wave of fast-breaking COVID-19 vaccines developed by Novavax, to the first-ever xenotransplant into a living human using only FDA-approved immunosuppressive medicines by United Therapeutics, Montgomery County is where life science companies seek to establish operations and deliver on their most ambitious projects.

Located next door to the nation’s capital, the county is home to more than 530 life science businesses creating life-saving cell and gene therapies, immunology and biopharmaceutical advances, and major research and development and manufacturing. Novavax, United Therapeutics, AstraZeneca, MilliporeSigma, REGENXBIO and many others continue to invest in the county,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Pharma / Biotech, States
Boosting biopharma R&D performance with a next-generation technology stack
Charting the path to patients
External innovation: Biopharma dealmaking to boost R&D productivity
Building a shared vision for pharma R&D–supplier partnerships
Healthcare Industry Trends – 2024 Annual Report

Share This Article